Philip E.J. Sanderson

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva”.

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.29.360370

N/A

0DataRank · unranked

10 citations

Jana Bagarova, Georgina Kerr, Dong-Dong Xia, Elsie Place, Devaveena Dey +12 more

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva

JCI Insight(2021)10.1172/jci.insight.95042

N/A

0DataRank · unranked

72 citations

Jana Bagarova, Georgina Kerr, Dong-Dong Xia, Elsie Place, Devaveena Dey +12 more

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment

Frontiers in Pharmacology(2022)10.3389/fphar.2022.918083

N/A

0DataRank · unranked

30 citations

Natalie R. Hagen, Elias Carvalho Padilha, Mengbi Yang, Pranav Shah, Catherine Z. Chen +6 more

Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19

ACS Infectious Diseases(2022)10.1021/acsinfecdis.2c00172

N/A

0DataRank · unranked

8 citations

John Janiszewski, Catherine Z. Chen, Miao Xu, Kelli M. Wilson, Stephen C. Kales +12 more

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, A Potential Oral Drug Candidate for COVID-19 Treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.07.478848

N/A

0DataRank · unranked

2 citations

Natalie R. Hagen, Elias Carvalho Padilha, Mengbi Yang, Pranav Shah, Catherine Z. Chen +6 more